Heteroarylakanoic acids as intergrin receptor antagonists

Details Heteroarylakanoic acids as intergrin receptor antagonists Heteroarylakanoic acids as intergrin receptor antagonists

2006-10-10

2006-10-10

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S122000, C546S193000, C546S269100, C514S300000, C514S340000

Reexamination Certificate

active

07119098

ABSTRACT:
The present invention relates to a class of compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of Formula (I), and methods of selectively antagonizing the ανβ3and/or the ανβ5integrin without significantly antagonizing the IIb/IIIa integrin.

REFERENCES:
patent: 5700823 (1997-12-01), Hirth et al.
patent: 5773646 (1998-06-01), Chandrakumar et al.
patent: 5849736 (1998-12-01), Wityak et al.
patent: 5852210 (1998-12-01), Chen et al.
patent: 6933304 (2005-08-01), Nagarajan et al.
patent: 92/07468 (1992-05-01), None
patent: 94/08577 (1994-04-01), None
patent: 97/44333 (1997-11-01), None
patent: 99/26945 (1999-06-01), None
patent: 99/30709 (1999-06-01), None
patent: 99/30713 (1999-06-01), None
patent: 00/07544 (2000-02-01), None
patent: 00/72801 (2000-12-01), None
patent: 01/24797 (2001-04-01), None

Affiliated with

Also associated with

Rating

Heteroarylakanoic acids as intergrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroarylakanoic acids as intergrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylakanoic acids as intergrin receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3705475